THE COST OF BETTER CARERESEARCHED OCTOBER 2026
Cheap GLP-1.
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
Starter program

OrderlyMeds semaglutide starter program review

The $224 three-month offer, the standard renewal rate and the limits of a package-price comparison.

OUR TAKE

The $224 three-month offer, the standard renewal rate and the limits of a package-price comparison.

Initial package
$224 / three months
Advertised renewal
$149/month
Six-month scenario
$671 at unchanged published rates

The package charge is the clearest number

OrderlyMeds advertises its compounded semaglutide starter program at $224 for three months for eligible new customers. The displayed $74 monthly headline is rounded: $224 divided by three is about $74.67. A reader budgeting the first charge should use the package total rather than multiplying the rounded headline and coming up two dollars short.[source]

The page separately presents transfer and standard plans. A person already taking treatment should confirm which category applies; the starter price is not a universal new-account coupon. Eligibility for a commercial offer also does not guarantee a prescription.

Calculate past the introductory shipment

The FAQ states a standard semaglutide rate of $149 per month after the starter program. Three months at the introductory total followed by three months at that rate produces a $671 six-month scenario. Over twelve months, the same unchanged assumptions would total $1,565. Neither number forecasts dose decisions, future offers or treatment continuation.[source]

OrderlyMeds says medication, the doctor visit, syringes and shipping are included. Confirm any exceptions and the policy for a prescription that cannot proceed before purchasing. A prepaid supply also raises questions about fulfillment timing and usable storage periods, which a price-only comparison cannot answer.

A compounded plan is its own category

This offer concerns a compounded injection, not Wegovy. FDA identifies dosing errors, storage concerns and misleading equivalence claims among the issues surrounding unapproved GLP-1 products. The care team and dispensing pharmacy should provide product-specific instructions, including how to measure the prescribed dose.[source]

Do not use a program-price review as a dosing guide. The practical value of this offer depends on an appropriate prescription, reliable dispensing and a plan for clinical follow-up as well as the bill. Our OrderlyMeds brand review examines the other entry paths.

Compare the package with the right alternative

The relevant competing quote is a clinician-approved compounded injection plan covering the same period, with the same included services clearly listed. An insurance copay for a brand-name drug or a care-only membership is a different category. If an approved medication is clinically suitable and accessible, its actual out-of-pocket cost deserves a separate comparison rather than being omitted because a starter package looks inexpensive.

Write down the renewal date alongside the total. If the introductory package ends during travel or before a planned follow-up, ask how the next consultation and shipment are scheduled. Avoid assuming an advertised turnaround is a delivery guarantee for your address.

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.

  1. OrderlyMeds: plan pricing and renewal termsOfficial source; commercial claims are attributed to the provider. · Checked October 10, 2026
  2. FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags · Checked October 10, 2026

Keep reading